Tokyo, Feb. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060534) titled 'Survey on the Understanding of Placebos in Japan' on Jan. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University
Condition:
Condition - Healthy Adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the general Japanese population's level of knowledge about placebo and the placebo effect, their preference for explanations, and their willingness and acceptance of placebo use in treatment.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthy adults aged 18 years or older.
Native Japanese speakers with the ability to understand and respond in Japanese.
Key exclusion criteria - No specific exclusion criteria were defined.
Target Size - 400
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 01 Month 21 Day
Anticipated trial start date - 2026 Year 02 Month 01 Day
Last follow-up date - 2026 Year 02 Month 28 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069247
Disclaimer: Curated by HT Syndication.
